SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
20380656
Source:
http://linkedlifedata.com/resource/pubmed/id/20380656
Search
Subject
(
62
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0011860
,
umls-concept:C0030705
,
umls-concept:C0034656
,
umls-concept:C0206012
,
umls-concept:C0332161
,
umls-concept:C0332307
,
umls-concept:C1414141
,
umls-concept:C1999216
,
umls-concept:C2587213
,
umls-concept:C2828326
pubmed:issue
4
pubmed:dateCreated
2010-4-12
pubmed:abstractText
To determine efficacy and tolerability of dutogliptin, a dipeptidyl peptidase 4 (DPP4) inhibitor, in patients with type 2 diabetes mellitus.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/100883645
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Boronic Acids
,
http://linkedlifedata.com/resource/pubmed/chemical/Hemoglobin A, Glycosylated
,
http://linkedlifedata.com/resource/pubmed/chemical/Hypoglycemic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Placebos
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1463-1326
pubmed:author
pubmed-author:AlpizarMM
,
pubmed-author:BennettCC
,
pubmed-author:CherringtonJ MJM
,
pubmed-author:GunstK VKV
,
pubmed-author:O'FarrellA MAM
,
pubmed-author:OOIS KSK
,
pubmed-author:PHX1149-PROT202 Study Group
,
pubmed-author:PattziH M RHM
,
pubmed-author:PitaleSS
pubmed:issnType
Electronic
pubmed:volume
12
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
348-55
pubmed:meshHeading
pubmed-meshheading:20380656-Adolescent
,
pubmed-meshheading:20380656-Adult
,
pubmed-meshheading:20380656-Aged
,
pubmed-meshheading:20380656-Boronic Acids
,
pubmed-meshheading:20380656-Diabetes Mellitus, Type 2
,
pubmed-meshheading:20380656-Dose-Response Relationship, Drug
,
pubmed-meshheading:20380656-Double-Blind Method
,
pubmed-meshheading:20380656-Drug Administration Schedule
,
pubmed-meshheading:20380656-Female
,
pubmed-meshheading:20380656-Hemoglobin A, Glycosylated
,
pubmed-meshheading:20380656-Humans
,
pubmed-meshheading:20380656-Hypoglycemic Agents
,
pubmed-meshheading:20380656-Male
,
pubmed-meshheading:20380656-Middle Aged
,
pubmed-meshheading:20380656-Placebos
,
pubmed-meshheading:20380656-Treatment Outcome
,
pubmed-meshheading:20380656-Young Adult
pubmed:year
2010
pubmed:articleTitle
Dutogliptin, a selective DPP4 inhibitor, improves glycaemic control in patients with type 2 diabetes: a 12-week, double-blind, randomized, placebo-controlled, multicentre trial.
pubmed:affiliation
Instituto Mexicano de Investigaciones Clinicas, Mexico City, Mexico.
pubmed:publicationType
Journal Article
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't
,
Multicenter Study